Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Hepatitis C virus NS3-NS4A protease** is a membrane-associated, multifunctional viral enzyme complex essential for the replication of hepatitis C virus (HCV). The complex consists of the NS3 protein, which has both an N-terminal serine protease domain (amino acids 1–180) and a C-terminal RNA helicase domain, and the cofactor NS4A, an 11-amino-acid peptide crucial for optimal folding and activity of the protease[3]. The protease cleaves the HCV polyprotein at specific sites (3–4A, 4A4B, 4B5A, 5A5B), enabling production of viral nonstructural proteins necessary for replication. Additionally, NS3-NS4A protease cleaves key adaptor proteins in the host innate immune signaling pathways (such as MAVS and TRIF), allowing the virus to evade the immune response[1][2][3]. The essential role of this enzyme in both viral replication and immune evasion makes it a validated target for antiviral drugs, and several direct-acting antivirals (DAAs) have been developed to inhibit this protease, significantly improving treatment outcomes for chronic HCV infection[2][4][6].
Reversible or irreversible inhibition of the NS3-NS4A serine protease active site, blocking polyprotein processing[2][4][6]. Inhibition of viral RNA replication[2][6]. Restoration of host innate antiviral signaling (by preventing cleavage of host proteins such as MAVS and TRIF)[6].
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus NS3-NS4A protease (HCV NS3-NS4A protease (sometimes written as HCV NS3/4A protease)).